SUPERNOVA is a large Phase III global trial providing the only efficacy data in immunocompromised patients
The funds raised from the Whitathon run are utilized to treat underprivileged children suffering from Retinoblastoma
Cresset’s new India site will support the growing demands of Cresset’s APAC customer base
Ashland's nutraceuticals business supplies a broad portfolio of active ingredients and formulation aids to nutritional product companies
The company has posted net profit of Rs.118.82 crores for the Financial Year ended March 31, 2024
Cellectis is also eligible to receive an investigational new drug (IND) option fee and development
Investing in Malaysia's largest clinic operator to expand the healthcare business
Wipro's MPPP360 platform will assist Independent Health in streamlining the payment process to seamlessly integrate these new provisions
Late-breaker Phase 3 STRIDE-10 trial presented as an oral presentation at European Society of Clinical Microbiology and Infectious Diseases
Philips also concluded an agreement with insurers to pay Philips EUR 540 million to cover Respironics recall-related product liability claims
Subscribe To Our Newsletter & Stay Updated
